Brief: GNI Group gets approval for clinical trial in China for drug of diabetic nephropathy
17/08/2016 09:16
Aug 17 (Reuters) - GNI Group Ltd 2160.T :
* Says it received approval from China Food and Drug
Administration for a pulmonary fibrosis treatment drug's effect
on diabetic nephropathy
Source text in Japanese: https://goo.gl/unTXkT
Further company Coverage: 2160.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))